Health care startups in Guangdong, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Hypershell | Shenzhen | Series B | $50.0M | 2026-05-18 |
| MileBot Robotics | Shenzhen | Series B | $14.9M | 2026-08-26 |
| Aibo Medical Robot | Shenzhen | Series A | $14.1M | 2026-10-15 |
| Shanmu SHANMU | Shenzhen | Series A | $14.7M | 2026-05-06 |
| Hongxin Biology | Shenzhen | Series B | $14.0M | 2026-08-13 |
| Artivila Therapeutics | Shenzhen | Series A | $14.7M | 2026-06-23 |
| Edge Medical Robotics | Shenzhen | Series C | $200.0M | 2021-11-05 |
| Supermonkey | Shenzhen | Series E | $15.5M | 2021-05-06 |
8 rows of the CSV in 5 of its 18 columns.
- The 599 health care startups in Guangdong, China have raised $6.4B in total.
- 94 of them closed their most recent round in the last 12 months, $630.7M combined.
- The largest of those rounds is GeneMind Biosciences' $89.5M Series D, dated September 2026.
- The most recent is Libo Biotech's $15.0M Series A on 30 October 2026.
- Shenzhen Capital Group is an investor in 8 of them, more than any other fund.
- Biotech is the most common other sector, with 174 companies (29%).
- 25% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (40% of companies with a recorded size).
- 2 are unicorns, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
28 of 599| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Aibo Medical Robot | Aibo Medical Robot researches and develops robots for vascular interventional surgery. | Hardware | Shenzhen | Series A | $14.1M | 2026-10-15 | $33.0M | Lenovo Capital and Incubator Group (LCIG), CDH Investments, Long Hill Capital +2 | 2020 | |
| Medefa | Medefa uses synthetic biology to mass-produce novel PHA biomaterials. | Biotech | Zhuhai | Series B | $14.9M | 2026-09-02 | $16.3M | Motianshi Touzi, Taiping Innovation | 11 to 50 | 2019 |
| MileBot Robotics | MileBot Robotics develops robots for medical and healthcare applications. | Artificial intelligence | Shenzhen | Series B | $14.9M | 2026-08-26 | $14.9M | Lenovo Capital and Incubator Group (LCIG), Share Capital, Shangyuan Capital | 101 to 250 | 2016 |
| Hongxin Biology | Hongxin Biology develops mRNA drugs and delivers nucleic acid therapeutics to patients. | Biotech | Shenzhen | Series B | $14.0M | 2026-08-13 | $14.0M | Haiyuan Capital, Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group | 11 to 50 | 2021 |
| Sonosemi Medical | Sonosemi Medical provides medical devices for vascular interventional diagnosis and treatment. | Health care | Shenzhen | Series B | $27.3M | 2026-07-08 | $27.3M | Eight Roads Ventures, Co-Stone Venture Capital, Guangzhou Yuexiu Industrial Investment Fund +1 | 101 to 250 | 2020 |
| Artivila Therapeutics | Artivila Therapeutics uses artificial intelligence to discover new pharmaceutical drugs for patients. | Artificial intelligence | Shenzhen | Series A | $14.7M | 2026-06-23 | $53.3M | Highlight Capital, Med-Fine Capital, Hike Capital +2 | 11 to 50 | 2018 |
| Menovex | Menovex develops and markets laser medical devices for treating oral and skin conditions. | Health care | Shenzhen | Series B | $14.8M | 2026-06-02 | $14.8M | Infinity Equity | 2019 | |
| Yuansheng Intelligence | Yuansheng Intelligence manufactures intricate medical hardware for rehabilitation and nursing. | Health care | Dongguang | Seed | $1.5M | 2026-06-02 | $1.8M | Dongguan Songshan Lake Angel Fund, Yinchuang Capital | 11 to 50 | 2022 |
| Vivolight | Vivolight conducts medical research and develops intravascular interventional imaging technology. | Biotech | Nanshanqu | Series E | $13.9M | 2026-06-01 | $52.2M | CAS Star, TusStar | 51 to 100 | 2012 |
| Hypershell | Hypershell develops wearable exoskeletons that support walking, hiking, and cycling. | Artificial intelligence | Shenzhen | Series B | $50.0M | 2026-05-18 | $121.2M | MiraclePlus, Decent Capital, Vitalbridge Capital | 101 to 250 | 2021 |
| Shanmu SHANMU | Shanmu develops micro medical robots using digital microfluidic chipsets and artificial intelligence algorithms. | Artificial intelligence | Shenzhen | Series A | $14.7M | 2026-05-06 | $16.0M | QF Capital, Hofan Venture, Wanwu Capital +1 | 1 to 10 | 2020 |
| Ningkang Ruizhu | Ningkang Ruizhu develops targeted drugs. | Biotech | Zhuhai | Series A | $14.1M | 2025-12-05 | $25.6M | GF Qianhe Investment, RiverHead Capital, Hanne Capital +1 | 11 to 50 | 2019 |
| PulseCare | PulseCare is a medtech company that makes medical devices for cardiac and pan-vascular treatment. | Health care | Shenzhen | Series A | $14.0M | 2025-11-06 | $28.1M | Delian Capital, Tasly Capital, Tianfeng Capital | 11 to 50 | 2021 |
| AIMIRA Innovation Technology | AIMIRA Innovation Technology applies AI to medical diagnosis, plastic surgery, and anti-aging medicines. | Artificial intelligence | Guangzhou | Seed | $13.7M | 2025-09-16 | $13.7M | CDF-Capital, Jinding Capital, Boyuan Capital +1 | 2021 | |
| Tianchen Biotechnology | Tianchen Biotechnology develops and sells medical products for ophthalmology. | Biotech | Tianjin | Series C | $27.8M | 2025-06-03 | $41.7M | CMB International Capital Corporation | 2018 | |
| Zhiyi Pharmaceutics | Zhiyi Pharmaceutics researches and develops second-generation probiotics and live biotherapeutics. | Biotech | Guangzhou | Series C | $13.8M | 2024-03-28 | Shenzhen Capital Group, SDIC Venture Capital, Sinoking Capital | 51 to 100 | 2013 | |
| PVmed | PVmed focuses on AI-enhanced auxiliary diagnosis and treatment. | Artificial intelligence | Guangzhou | Series B | $12.7M | 2024-02-01 | $26.7M | China Growth Capital, Shenzhen Guozhong Venture Capital Management, COCOCapital +1 | 51 to 100 | 2017 |
| Enzymecode Biotechnology | Enzymecode develops and produces brain health nutritional raw materials and food ingredients. | Biotech | Tianjin | Angel | $1.4M | 2023-12-29 | Draper Dragon | 11 to 50 | 2017 | |
| Yuanyi Biotech | Yuanyi Biotech creates artificial microbial technologies and products. | Biotech | Tianjin | Series A | $13.7M | 2023-10-18 | $21.5M | Marathon Venture Partners, Haitang Fund, Ruipeng Touzi | 51 to 100 | 2021 |
| Fermion Technology | Fermion applies AI and deep learning to speed medicine development and expand treatment options. | Artificial intelligence | Guangzhou | Series B | $14.8M | 2022-07-18 | Welight Capital, Zhengxuan Investment, Challenjers Capital +1 | 51 to 100 | 2015 | |
| DMAI | DMAI builds cognitive AI platforms. | Artificial intelligence | Guangzhou | Series B | $74.6M | 2022-07-04 | IDG Capital, Lenovo Capital and Incubator Group (LCIG), CDH Investments +1 | 101 to 250 | 2017 | |
| Edge Medical Robotics | Edge Medical Robotics designs, develops, and commercializes surgical robot platforms and medical devices. | Hardware | Shenzhen | Series C | $200.0M | 2021-11-05 | $308.0M | Temasek, Mirae Asset Venture Investment, OrbiMed +1 | 11 to 50 | 2017 |
| Supermonkey | Supermonkey develops and operates a mobile app that provides fitness services. | Health care | Shenzhen | Series E | $15.5M | 2021-05-06 | CICC, PreAngel, Fosun RZ Capital +1 | 51 to 100 | 2014 | |
| e-ling | e-ling provides smart elderly care solutions and cloud services built on technology-driven platforms. | Health care | Nanshanqu | Seed | $7.8M | 2018-06-12 | $15.9M | China Highrun Capital Limited | 101 to 250 | 2014 |
| DiGiXMed | DiGiXMed develops ICU information systems and surgical anesthesia information systems. | Artificial intelligence | Nanshanqu | Angel | $475K | 2018-02-26 | $475K | Dongfang Shengding | 1 to 10 | 2015 |
| YORKTAL | YORKTAL develops digital medical imaging software. | Health care | Futian | Series A | $1.5M | 2018-01-02 | $1.5M | Flyfot Ventures | 51 to 100 | 2011 |
| SUWELL | SUWELL provides medical equipment and information technology software services. | Health care | Longhua | Angel | $431K | 2016-12-19 | $431K | Guosen H&S Investments | 11 to 50 | 2016 |
| iCarbonX Unicorn | iCarbonX is a China-based company that builds artificial intelligence platforms for health data. | Artificial intelligence | Shenzhen | Series A | $45.0M | 2016-07-15 | $200.0M | Share Capital, ProCapital | 51 to 100 | 2015 |
Table 1. Health care startups in Guangdong, China: the 28 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 599.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Hypershell | Hypershell develops wearable exoskeletons that support walking, hiking, and cycling. | Artificial intelligence | Shenzhen | Series B | $50.0M | 2026-05-18 | $121.2M | MiraclePlus, Decent Capital, Vitalbridge Capital | 101 to 250 | 2021 |
| 2 | Sonosemi Medical | Sonosemi Medical provides medical devices for vascular interventional diagnosis and treatment. | Health care | Shenzhen | Series B | $27.3M | 2026-07-08 | $27.3M | Eight Roads Ventures, Co-Stone Venture Capital, Guangzhou Yuexiu Industrial Investment Fund +1 | 101 to 250 | 2020 |
| 3 | MileBot Robotics | MileBot Robotics develops robots for medical and healthcare applications. | Artificial intelligence | Shenzhen | Series B | $14.9M | 2026-08-26 | $14.9M | Lenovo Capital and Incubator Group (LCIG), Share Capital, Shangyuan Capital | 101 to 250 | 2016 |
| 4 | Medefa | Medefa uses synthetic biology to mass-produce novel PHA biomaterials. | Biotech | Zhuhai | Series B | $14.9M | 2026-09-02 | $16.3M | Motianshi Touzi, Taiping Innovation | 11 to 50 | 2019 |
| 5 | Menovex | Menovex develops and markets laser medical devices for treating oral and skin conditions. | Health care | Shenzhen | Series B | $14.8M | 2026-06-02 | $14.8M | Infinity Equity | 2019 | |
| 6 | Artivila Therapeutics | Artivila Therapeutics uses artificial intelligence to discover new pharmaceutical drugs for patients. | Artificial intelligence | Shenzhen | Series A | $14.7M | 2026-06-23 | $53.3M | Highlight Capital, Med-Fine Capital, Hike Capital +2 | 11 to 50 | 2018 |
| 7 | Shanmu SHANMU | Shanmu develops micro medical robots using digital microfluidic chipsets and artificial intelligence algorithms. | Artificial intelligence | Shenzhen | Series A | $14.7M | 2026-05-06 | $16.0M | QF Capital, Hofan Venture, Wanwu Capital +1 | 1 to 10 | 2020 |
| 8 | Ningkang Ruizhu | Ningkang Ruizhu develops targeted drugs. | Biotech | Zhuhai | Series A | $14.1M | 2025-12-05 | $25.6M | GF Qianhe Investment, RiverHead Capital, Hanne Capital +1 | 11 to 50 | 2019 |
| 9 | Aibo Medical Robot | Aibo Medical Robot researches and develops robots for vascular interventional surgery. | Hardware | Shenzhen | Series A | $14.1M | 2026-10-15 | $33.0M | Lenovo Capital and Incubator Group (LCIG), CDH Investments, Long Hill Capital +2 | 2020 | |
| 10 | Hongxin Biology | Hongxin Biology develops mRNA drugs and delivers nucleic acid therapeutics to patients. | Biotech | Shenzhen | Series B | $14.0M | 2026-08-13 | $14.0M | Haiyuan Capital, Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group | 11 to 50 | 2021 |
Table 2. Health care startups in Guangdong, China: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Shenzhen Capital Group | Venture capital firm | Nanshan, China | 8 | 1% | ||
| 2 | Lenovo Capital and Incubator Group (LCIG) | Venture capital firm | Beijing, China | 5 | 1% | 3 | Aibo Medical Robot, MileBot Robotics, Zhonghe Gene |
| 3 | CDH Investments | Private equity firm | Kowloon City, Hong Kong | 4 | 1% | 1 | Aibo Medical Robot |
| 4 | IDG Capital | Private equity firm | Beijing, China | 4 | 1% | ||
| 5 | Vertex Ventures China | Venture capital firm | Beijing, China | 3 | 1% | ||
| 6 | Shanghai Biomedical Industrial Equity Investment Fund | Venture capital firm | Huangpu, China | 3 | 1% | ||
| 7 | Eight Roads Ventures | Venture capital firm | London, United Kingdom | 3 | 1% | 1 | Sonosemi Medical |
| 8 | Legend Capital | Venture capital firm | Beijing, China | 3 | 1% | ||
| 9 | Fortune Venture Capital | Venture capital firm | Shenzhen, China | 3 | 1% | ||
| 10 | Shenzhen Guozhong Venture Capital Management | Venture capital firm | Shenzhen, China | 3 | 1% | ||
| 11 | SDIC Venture Capital | Venture capital firm | Xicheng, China | 3 | 1% | ||
| 12 | Cowin Capital | Private equity firm | Shenzhen, China | 3 | 1% | ||
| 13 | BioVenture | Venture capital firm | Suzhou, China | 3 | 1% | ||
| 14 | Haitang Fund | Venture capital firm | Nankai, China | 3 | 1% | 1 | Zhonghe Gene |
| 15 | Share Capital | Venture capital firm | Shenzhen, China | 2 | 0% | 1 | MileBot Robotics |
Table 3. Health care startups in Guangdong, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 174 | 29% | $3.6B |
| Software | 74 | 12% | $1.0B |
| Hardware | 45 | 8% | $587.2M |
| Artificial intelligence | 38 | 6% | $647.6M |
| Commerce | 18 | 3% | $24.2M |
| Education | 13 | 2% | $19.0M |
| Energy | 6 | 1% | $9.7M |
| Fintech | 3 | 1% | $27.6M |
| Cybersecurity | 2 | 0% |
Table 4. Health care startups in Guangdong, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Health care startups in Guangdong, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Health care startups in Guangdong, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 1% | |
| October 2026 | 8 | 9% | $84.5M |
| September 2026 | 5 | 5% | $104.3M |
| August 2026 | 9 | 10% | $67.1M |
| July 2026 | 8 | 9% | $43.6M |
| June 2026 | 12 | 13% | $79.3M |
| May 2026 | 5 | 5% | $79.4M |
| April 2026 | 6 | 6% | $45.1M |
| March 2026 | 9 | 10% | $73.8M |
| February 2026 | 6 | 6% | $14.4M |
| January 2026 | 17 | 18% | $22.1M |
| December 2025 | 5 | 5% | $15.7M |
| November 2025 | 3 | 3% | $1.4M |
Table 7. Health care startups in Guangdong, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 86 | 14% | $613.6M |
| 2025 | 65 | 11% | $524.7M |
| 2024 | 53 | 9% | $295.9M |
| 2023 | 65 | 11% | $355.5M |
| 2022 | 43 | 7% | $575.7M |
| 2021 | 43 | 7% | $908.6M |
Table 8. Health care startups in Guangdong, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 44 | 7% |
| 2020 to 2022 | 101 | 17% |
| 2015 to 2019 | 244 | 42% |
| 2010 to 2014 | 118 | 20% |
| Before 2010 | 80 | 14% |
Table 9. Health care startups in Guangdong, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 44 | 10% |
| 11 to 50 | 183 | 40% |
| 51 to 100 | 107 | 23% |
| 101 to 250 | 57 | 12% |
| 251 to 500 | 36 | 8% |
| 501 to 1,000 | 18 | 4% |
| 1,001 to 5,000 | 11 | 2% |
| 5,001 to 10,000 | 2 | 0% |
| 10,001 or more | 2 | 0% |
Table 10. Health care startups in Guangdong, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in Guangdong, China. On 16 November 2026 that is 599 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 28 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 599 rows: 224 have no round amount, 0 no city and 234 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Guangdong, China are on the list?
- 599, in the file dated 16 November 2026. 94 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 599 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.